Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-16 of 16 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypesSchroth, W.; Antoniadou, L.; Fritz, P.; Schwab, M.; Muerdter, T.; Zanger, U.; Simon, W.; Eichelbaum, M.; Brauch, H.
2009Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocolsStanulla, M.; Schaeffeler, E.; Moricke, A.; Coulthard, S.; Cario, G.; Schrauder, A.; Kaatsch, P.; Dordelmann, M.; Welte, K.; Zimmerman, M.; Reiter, A.; Eichelbaum, M.; Riehm, H.; Schrappe, M.; Schwab, M.
2008Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study GroupSchwab, M.; Zanger, U.; Marx, C.; Schaeffeler, E.; Klein, K.; Dippon, J.; Kerb, R.; Blievernicht, J.; Fischer, J.; Hofmann, U.; Bokemeyer, C.; Eichelbaum, M.
2010CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratificationSchroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.
2010Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expressionHennig, G.; Gehrmann, M.; Stropp, U.; Brauch, H.; Fritz, P.; Eichelbaum, M.; Schwab, M.; Schroth, W.
2009Pharmacogenomics of Tamoxifen TherapyBrauch, H.; Murdter, T.; Eichelbaum, M.; Schwab, M.